Resources

It’s Raining Biotech SPACs!

SPACs are all the rage today. With the IPO market booming and public investors seeking better returns, blank check companies called “Special Purpose Acquisition Companies” (SPACs) have been fueling up their tanks and chasing down their merger targets. New ones are...

read more

Unemployment still rising in US

9 October The US economy showed some signs of recovery in the third quarter of 2020 but unemployment claims continue to remain above pre-pandemic levels. Layoffs are expected to rise over the next few months hampering recovery. Ben Casselman, economics/business/data...

read more

Orthofix Medical launches new bone graft delivery system

Orthofix Medical has launched a new O-GENESIS Graft Delivery System together with AlloQuent Structural Allograft Q-Pack, a ready-to-use form of cervical and lumbar spacers for allograft procedures. The O-GENESIS Graft Delivery System is designed to provide allograft,...

read more

Eurozone to retain fiscal support until pandemic passes

8 October Francesco Saraceno, Italian economist, shared an article on European Central Bank (ECB) President Christine Lagarde’s plans to retain monetary support until the crisis created by the Covid-19 pandemic is over. She noted that the policies adopted in the euro...

read more

Kymera Therapeutics Goes Public

We are proud to announce that Kymera Therapeutics went public, trading on the Nasdaq: KYMR, and announced an important collaboration with Sanofi. Learn more. The post Kymera Therapeutics Goes Public appeared first on Atlas Venture.

read more

Evolution Of The Biotech IPO Markets From Busted To Booming

In the excitement of today’s biotech IPO market, and the bullish period since 2013, it’s almost hard to remember how painful the equity capital markets were back in the day. Read more. The post Evolution Of The Biotech IPO Markets From Busted To Booming appeared first...

read more

(Do Not) Let The Chips Fall Where They May

“You gotta know when to hold ‘em, know when to fold ‘em, know when to walk away, know when to run…” Kenny Rogers’ The Gambler, a song now enshrined in the Library of Congress’ National Recording Registry, is what I consider the soundtrack of business development. It...

read more

Kymera Debuts On The Public Markets

August continued to show the biotech market’s resilience in the face of the COVID pandemic with one of the biggest venture fund flows for the month ever, and a half a dozen IPOs. Kymera Therapeutics was one of those August IPOs, and as its co-founder I wanted to share...

read more

Zooming in on What Matters!

A lifetime ago, in May 2020, I had the honor of writing my first “From the Trenches” blog. I highlighted our long-range planning (LRP) approach at Xilio Therapeutics reframed as Leaders Require Purpose. I shared our belief that aligning our long and mid-range planning...

read more